| Predicate |
Object |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-485
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-44 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-485
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-08 |
| filingDate |
2016-05-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2022-03-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate |
2022-03-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-102375798-B1 |
| titleOfInvention |
Pharmaceutical Formulation for Sustained Release of Sebacoyl Dinalbuphine Ester |
| abstract |
The present invention provides an injectable extended-release pharmaceutical formulation comprising a nalbuphine ester prodrug homogeneously dissolved in a solution comprising a pharmaceutically acceptable oil and an oil-miscible fixed solvent, as well as the above It relates to a method for preparing the formulation and to its medical use. The present invention further provides a method for controlling the duration of action of a formulation by varying the ratio of a pharmaceutically acceptable oil to an oil-miscible fixed solvent. |
| priorityDate |
2015-05-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |